Document is current
Any future updates will be listed below
-
Authors
Ugradar, Shoaib
Goldberg, Robert A.
Douglas, Raymond S.
- License Information
-
More Information
Article History
Received: 29 March 2022
Revised: 20 June 2022
Accepted: 14 July 2022
First Online: 26 July 2022
Competing interests
: SU: None. RAG: None. RD - Consultant Horizon Therapeutics, Immunovant.
